Dianosic

French tech company | Builders Republic

About

Clinical-stage medtech developing resorbable intranasal implants that release medication directly inside the nasal cavity over time — an insert-and-forget platform for chronic rhinitis and sinusitis, with potential nose-to-brain delivery for neurological conditions, plus a marketed intranasal balloon device to stop nosebleeds.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series B
Founded
2017
City
STRASBOURG
Region
Grand Est
Tracked rounds
2
Amount raised
9.2 M€ raised since 2020

Funding rounds

  • Series B — 2025
  • Seed — 2023

Investors